Cita APA

Xiao, Z., Huang, X., Xie, B., Xie, W., Huang, M., & Lin, L. (2020). Primary Resistance to Brigatinib in a Patient with Lung Adenocarcinoma Harboring ALK G1202R Mutation and LIPI-NTRK1 Rearrangement. Onco Targets Ther.

Citación estilo Chicago

Xiao, Zhiwei, Xuewu Huang, Biyuan Xie, Wenzhuan Xie, Mengli Huang, y Lizhu Lin. "Primary Resistance to Brigatinib in a Patient With Lung Adenocarcinoma Harboring ALK G1202R Mutation and LIPI-NTRK1 Rearrangement." Onco Targets Ther 2020.

Cita MLA

Xiao, Zhiwei, et al. "Primary Resistance to Brigatinib in a Patient With Lung Adenocarcinoma Harboring ALK G1202R Mutation and LIPI-NTRK1 Rearrangement." Onco Targets Ther 2020.